Ticker Symbol: MTNB
Matinas Biopharma Holdings Inc
$1.11 - 20-12-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001582554
Company Profile
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care for patients in areas of significant unmet medical need. Company leadership has a deep history and knowledge of drug development and is supported by a world-class team of scientific advisors.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Suite 302
Website: www.matinasbiopharma.com
CEO: Jerome Jabbour
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.12
Change:
$0.00
(
-2.70%)
Days Range: $0.12 - $0.13
Beta: 1.89
52wk. High: $0.89
52wk. Low: $0.11
Ytd. Change -77.50%
50 Day Moving Average: $0.17
200 Day Moving Average: $0.34
Shares Outstanding: 217264526
Valuation
Market Cap: 2.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A